Abstract
The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Current Topics in Medicinal Chemistry
Title:Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging
Volume: 13 Issue: 4
Author(s): Jung Hwan Lee
Affiliation:
Keywords: Aptamer, aptamer-conjugated nanoparticles, conjugation, medical imaging, diagnosis, nanoparticles
Abstract: The development of imaging probes based on advances in nanotechnology aims to substantially improve specificity and sensitivity of diagnostic imaging through non-invasive and quantitative detection of specific biomolecules in living subjects. A promising class of molecular imaging probes consists of nanoparticles (NPs) functionalized with a certain targeting agent. Such targeting agents can, for instance, be selected to recognize disease-related biomarkers located on the cell surface. Among the possible agents that direct the NPs to the target site, aptamers, being single-stranded DNA or RNA molecules that can be designed to bind preselected targets such as proteins and peptides with high affinity and specificity, play an increasingly important role. Indeed, aptamers selected against proteins or whole cells have been conjugated to a variety of nanomaterials (NMs) such as Au NPs, quantum dots (QD), and superparamagnetic iron oxide NPs (SPIONs). These probes have successfully been used for cell imaging, both in vitro and in vivo, by optical imaging, magnetic resonance imaging (MRI), computed tomography (CT), and positron-emission tomography (PET). This review presents an overview of the commonly used techniques involved in conjugating aptamer to NPs and their application as probes in cellular or in vivo imaging.
Export Options
About this article
Cite this article as:
Lee Jung Hwan, Conjugation Approaches for Construction of Aptamer-Modified Nanoparticles for Application in Imaging, Current Topics in Medicinal Chemistry 2013; 13 (4) . https://dx.doi.org/10.2174/1568026611313040010
DOI https://dx.doi.org/10.2174/1568026611313040010 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Xanthohumol: A Metabolite with Promising Anti-Neoplastic Potential
Anti-Cancer Agents in Medicinal Chemistry Targeting G-Quadruplex DNA for Cancer Chemotherapy
Current Drug Discovery Technologies Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Current Stem Cell Research & Therapy ROCK Inhibitor Y-27632 Promotes Human Retinal Pigment Epithelium Survival by Altering Cellular Biomechanical Properties
Current Molecular Medicine MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Identification of Disease States and Response to Therapy in Humans by Utilizing the Biomarker EGFR for Targeted Molecular Imaging
Current Protein & Peptide Science Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Application of Machine Learning in Animal Disease Analysis and Prediction
Current Bioinformatics Targeting the Phosphatidylinositol 3-Kinase/AKT Pathway for the Treatment of Multiple Myeloma
Current Medicinal Chemistry Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Nanocrystals: From Raw Material to the Final Formulated Oral Dosage Form - A Review
Current Pharmaceutical Design NOB1: A Potential Biomarker or Target in Cancer
Current Drug Targets Acute Neurological Manifestations of Porphyrias and its Types: A Systematic- Review
Cardiovascular & Hematological Agents in Medicinal Chemistry ER Stress and Autophagy
Current Molecular Medicine Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets Vagotomy and Gastric Tumorigenesis
Current Neuropharmacology Protein Tyrosine Phosphatases: Strategies for Distinguishing Proteins in a Family Containing Multiple Drug Targets and Anti-Targets
Current Pharmaceutical Design Molecular Based Drug Targets for Idiopathic Pulmonary Fibrosis
Current Respiratory Medicine Reviews Immune System Modulates the Function of Adult Neural Stem Cells
Current Immunology Reviews (Discontinued)